Literature DB >> 9490660

Exogenous nitric oxide enhances neutrophil cell death and DNA fragmentation.

J D Fortenberry1, M L Owens, M R Brown, D Atkinson, L A Brown.   

Abstract

Inhaled nitric oxide (NO) is an important new therapeutic agent used to treat pulmonary arterial hypertension in a variety of disease states. However, the effects of NO on cells in the lung are uncertain. Previously, we have shown that NO gas depresses neutrophil oxidative cell function and increases neutrophil cell death. The purpose of this in vitro study was to determine the mechanism of neutrophil death. We hypothesized that NO hastened cell death by inducing apoptosis. To mimic the clinical environment of patients with respiratory failure, we also studied the effects of hyperoxia on neutrophil cell viability and apoptosis. Isolated human neutrophils were exposed to 80% O2 (O2), NO at 20 ppm in room air (NO/RA), 20 ppm NO blended with 80% O2 (NO/O2), or RA alone (control) for 2 to 24 h. Experiments were repeated with NO concentrations of 5 and 50 ppm and with 20 ppm in the presence of superoxide dismutase (SOD). Neutrophils were also incubated in the absence or presence of neutrophil stimulant fMLP (10 nM). Neutrophil cell viability was measured by fluorescence viability/cytotoxicity assay. Neutrophil apoptosis was assessed by cell death detection ELISA for histone-associated DNA fragments, TdT transferase-mediated fluorescence-labeled dUTP nick end labeling (TUNEL) assay, and DNA fragmentation gel electrophoresis. NO/O2-exposed neutrophils showed decreased viability at 2 h (31.7 +/- 3.7%, mean % viability +/- SD) compared with control (94.7 +/- 4.7%), O2 (75.6 +/- 9.3%), and NO/RA (62.8 +/- 14.9%; P < 0.05 by ANOVA; n = 9). Although control neutrophils demonstrated marked apoptosis at 24 h, there was no significant apoptosis at 2, 4, or 6 h (P < 0.001 by Kruskal-Wallis, n = 20) as assessed by ELISA and TUNEL assays. When compared with RA controls at 2 h, neutrophils exposed to NO/O2 showed significantly more apoptosis (292% of control, range: 106 to 2,488%, P < 0.001 by ANOVA and Kruskal-Wallis) but not with exposure to NO/RA or O2 alone. These findings were confirmed by TUNEL assay (n = 4, P < 0.05). NO/ RA and NO/O2-exposed neutrophils demonstrated both evidence of necrosis and enhanced DNA fragmentation at 2 h by gel electrophoresis (n = 2). Fifty parts per million NO produced similar findings, but exposure to 5 ppm NO did not induce significant DNA fragmentation. Coincubation with SOD inhibited NO/ O2-associated apoptosis, suggesting peroxynitrite contributed to cell death. Stimulation with fMLP did not alter apoptosis induced in neutrophils exposed to NO/RA or NO/O2. We conclude that exogenous NO gas, at clinically relevant concentrations under hyperoxic conditions, induces cell death in neutrophils in part by enhancing DNA fragmentation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490660     DOI: 10.1165/ajrcmb.18.3.2875

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

1.  Enterotoxigenic Escherichia coli modulates host intestinal cell membrane asymmetry and metabolic activity.

Authors:  Amber M Johnson; Radhey S Kaushik; Nicholas J Rotella; Philip R Hardwidge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

2.  Fas-mediated apoptosis of neutrophils in sera of patients with infection.

Authors:  I E Nwakoby; K Reddy; P Patel; N Shah; S Sharma; M Bhaskaran; N Gibbons; A A Kapasi; P C Singhal
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  High-dose nitric oxide inhalation increases lung injury after gastric aspiration.

Authors:  N D Nader; P R Knight; I Bobela; B A Davidson; K J Johnson; F Morin
Journal:  Anesthesiology       Date:  1999-09       Impact factor: 7.892

Review 4.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

5.  miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

Authors:  Myriem Boufraqech; Naris Nilubol; Lisa Zhang; Sudheer Kumar Gara; Samira M Sadowski; Amit Mehta; Mei He; Sean Davis; Jennifer Dreiling; John A Copland; Robert C Smallridge; Martha M Quezado; Electron Kebebew
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

6.  Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats.

Authors:  Richard L Auten; Stanley N Mason; Mary H Whorton; William R Lampe; W Michael Foster; Ronald N Goldberg; Bo Li; Jonathan S Stamler; Kathryn M Auten
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

7.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

Review 8.  The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis.

Authors:  Nikunj K Chokshi; Yigit S Guner; Catherine J Hunter; Jeffrey S Upperman; Anatoly Grishin; Henri R Ford
Journal:  Semin Perinatol       Date:  2008-04       Impact factor: 3.300

9.  Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis.

Authors:  Joanna Murray; Carol Ward; Joseph T O'Flaherty; Ian Dransfield; Christopher Haslett; Edwin R Chilvers; Adriano G Rossi
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes.

Authors:  Philippe Holzmuller; Denis Sereno; Mireille Cavaleyra; Isabelle Mangot; Sylvie Daulouede; Philippe Vincendeau; Jean-Loup Lemesre
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.